Cargando…

1167. Got Micafungin? The Incidence of Fungemia in Patients with Septic Shock

BACKGROUND: Timely administration of antibiotics in patients presenting with sepsis decreases mortality, however evidence evaluating empiric antifungal coverage has been inconclusive. Recent data have shown no mortality benefit of empiric antifungal therapy in patients with ICU-acquired sepsis. Desp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piche, Mackenzie, Campion, Maureen, Adeel, Alina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776458/ http://dx.doi.org/10.1093/ofid/ofaa439.1353

Ejemplares similares

1167. Hospital Readmissions among Infants Diagnosed with Early-Onset Neonatal Sepsis in Connecticut
por: Hudon, Rebecca, et al.
Publicado: (2021)

The Plague of 1167
Publicado: (1895)

Successful therapy of Candida pulcherrima fungemia in a premature newborn with liposomal amphotericin B and micafungin
por: Mpakosi, Alexandra, et al.
Publicado: (2016)

61. Evaluation of the Impact of a Micafungin Time-Out Protocol for Hospitalized Patients
por: Williams, Kelsey N, et al.
Publicado: (2020)

680. Month Long Fungemia due to Candida auris Endocarditis
por: khan, Haseeba, et al.
Publicado: (2021)

594. Micafungin Prophylaxis in Acute Myeloid Leukemia Adult Patients Undergoing Induction Chemotherapy
por: Ross, Justine Abella, et al.
Publicado: (2021)

A case of breakthrough Candida parapsilosis fungemia during micafungin therapy for a Candida glabrata bloodstream infection
por: Norimatsu, Yuta, et al.
Publicado: (2017)

Pooled analysis of safety for micafungin
por: Cornely, OA, et al.
Publicado: (2008)

Pharmacokinetics of micafungin in patients with severe burn injuries
por: Sasaki, J, et al.
Publicado: (2012)

Pharmacokinetics of micafungin in patients with severe burn injuries
por: Sasaki, J, et al.
Publicado: (2011)

1179. Septic shock in Coccidioides immitis Infection
por: Wisniewski, Piotr, et al.
Publicado: (2020)

732. Evaulation of Micafungin Treatment at Pediatric Patients: A cross-sectional Study from Tertiary Pediatric Centre
por: Arıkan, Kamile, et al.
Publicado: (2020)

348. Characteristics and Outcomes in Hospitalized Patients with Covid-19 Complicated by Fungemia: A Single Center Retrospective Study
por: Zahra, Aleena, et al.
Publicado: (2021)

Pharmacokinetics of micafungin in adult patients with invasive candidiasis and candidaemia
por: Kuse, ER, et al.
Publicado: (2008)

1167. Trends in Multi-Drug-Resistant Gonorrhea, Gonococcal Isolate Surveillance Project, United States, 1987–2016
por: St. Cyr, Sancta, et al.
Publicado: (2018)

1167. Dialysis-Related Bloodstream Infections: A Pre- and Post-ClearGuard HD Cap Conception Study
por: Li, William, et al.
Publicado: (2019)

Effect of hydrocortisone therapy on outcome and the incidence of infection in patients with septic shock
por: Hayami, H, et al.
Publicado: (2009)

Micafungin for the treatment of pediatric invasive fungal infections
por: Arrieta, A, et al.
Publicado: (2009)

378. Candida auris Fungemia: Risk Factors and Outcome
por: Adam, Rodney, et al.
Publicado: (2018)

412. Clinical and Pharmacoeconomic Evaluation of Antifungal Prophylaxis With Continuous Micafungin Compared to Posaconazole With Micafungin Bridging in Patients Undergoing Allogeneic Stem Cell Transplantation: A 6-Year Cohort Analysis
por: Heimann, Sebastian M, et al.
Publicado: (2018)

1167. The Value of Influenza Vaccination in the Older Adult Population. A Stochastic Model Estimation of the benefit of vaccination to prevent the Severe Outcomes in the U.S.
por: Pelton, Stephen I, et al.
Publicado: (2023)

Candida dubliniensis Fungemia Leading to Infective Endocarditis and Septic Pulmonary Emboli
por: Jafroodifar, Abtin, et al.
Publicado: (2023)

Kinetics of immunoglobulins in septic shock patients
por: Siqueira, C, et al.
Publicado: (2011)

178. Comparing the Incidence of Multidrug Resistant Bacteremia, Fungemia and Hospital-acquired Clostridioides difficile Infection in COVID-19 Versus Non-COVID-19 Patients: a Single Hospital, One-year Observational Study in New York City
por: Chiu, Chia-Yu, et al.
Publicado: (2021)

Risk Factors for Candidemia as Compared with Patients with Negative Blood Cultures Placed on Empiric Micafungin
por: Carr, Amy, et al.
Publicado: (2017)

Biochemical and haematologic predictors of fungemia in previous colonised ICU patients
por: Bartola, A, et al.
Publicado: (1999)

Prognostic factors of septic shock
por: Quenot, JP, et al.
Publicado: (2012)

Fluid responsiveness in septic shock
por: Righetti, F, et al.
Publicado: (2014)

Homocysteine levels in septic shock
por: Mateu Campos, L, et al.
Publicado: (2015)

Cytokine levels is septic shock
por: Mateu Campos, L, et al.
Publicado: (2015)

Burden of septic shock in the uk
por: Andersson, F, et al.
Publicado: (2015)

Incidence and Clinical Predictors of Ocular Candidiasis in Patients with Candida Fungemia
por: Khalid, Ayesha, et al.
Publicado: (2014)

2243. Patterns of Micafungin Prescribing in the Intensive Care Unit in an Observational Retrospective Cohort
por: Cozzi, Francesca E, et al.
Publicado: (2023)

Incidence of severe sepsis and septic shock in german intensive care units - the insep study
por: Marx, G
Publicado: (2015)

Coagulation profile in hyperglycemic septic shock patients
por: Sanches, LC, et al.
Publicado: (2010)

Serum lipids analysis in septic shock patients
por: Nogueira, AC, et al.
Publicado: (2007)

Serum lipids analysis in septic shock patients
por: Cappi, S, et al.
Publicado: (2004)

Glibenclamide dose response in patients with septic shock
por: Morelli, A, et al.
Publicado: (2007)

Outcome of septic shock in patients with malignancies and neutropenia
por: Furmanchuk, D
Publicado: (2005)

Why measure endotoxin in septic shock patients?
por: Monti, G, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_5skbfm4ai446opia2b3ua2ufgt